Page 18 - Cell Stem News Today

A method that malignant tumours use to remotely prevent the emergence of an immune response that would halt their growth has been discovered by researchers at Baylor College of Medicine and associated institutions.

Technology could potentially lead to faster genetic gains in beef or dairy production or to reducing disease incidence in the animals.

Researchers at Baylor College of Medicine and collaborating institutions have identified a strategy cancerous tumors use to remotely disrupt the development of an immune response that could stop their growth.

In a recent study published in the journal Cell Stem Cell, researchers hypothesized that pacemaker-like activity of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) resulted in engraftment arrhythmias (EAs), which hampers the clinical use of cell-based therapy using hPSC-CMs for treatment of myocardial infarction (MI).

Many patients deal with brain fog, extreme fatigue, and severe headaches

From fad diets and vitamins to “blood washing” and stem cell therapy, long COVID patients are seeking out experimental therapies in a desperate bid to find hope and relief from debilitating symptoms.

Embryos made from stem cells, rather than an egg and sperm, appear to generate a short-lived pregnancy-like response in monkeys.

University of Washington researchers discovered why cell transplants used to repair damage after a heart attack cause arrhythmias and found a possible alternative

More than 3 years after the pandemic hit, there are still no established, effective interventions or tools -- let alone a cure -- for patients grappling with post-COVID symptoms.

Researchers have developed a new method to distinguish between cancerous and healthy stem cells and progenitor cells from samples of patients with acute myeloid leukemia (AML), a disease driven by malignant blood stem cells that have historically been difficult to identify.